Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
77.40
-0.19 (-0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Moderna Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates
June 15, 2021
From
Moderna, Inc.
Via
Business Wire
Dr. Paul Burton to Join Moderna as Chief Medical Officer
June 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
June 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
June 11, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States
June 10, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
June 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents
June 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
June 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
June 03, 2021
From
Moderna, Inc.
Via
Business Wire
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market
June 03, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility
June 02, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands
June 02, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine
June 01, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine
June 01, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at Upcoming Investor Conferences in June 2021
May 28, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Fourth Annual Science Day
May 27, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents Meets Primary Endpoint and Plans to Submit Data to Regulators in Early June
May 25, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline
May 24, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
May 22, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and South Korea Explore Collaboration on mRNA Vaccines
May 22, 2021
From
Moderna, Inc.
Via
Business Wire
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
May 21, 2021
From
Moderna, Inc.
Via
Business Wire
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s COVID-19 Vaccine
May 21, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Host Fourth Annual Science Day on May 27, 2021
May 19, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Establish an International Business Services Hub in Warsaw, Poland
May 19, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine
May 12, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at the Bank of America 2021 Healthcare Conference
May 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
May 06, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses
May 06, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern
May 05, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Expansion of its Manufacturing Technology Center in Massachusetts
May 04, 2021
From
Moderna, Inc.
Via
Business Wire
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.